Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.

Apical membrane antigen 1 (AMA1) is one of the best-studied blood-stage malaria vaccine candidates. When an AMA1 vaccine was tested in a malaria naïve population, it induced functionally active antibodies judged by Growth Inhibition Assay (GIA). However, the same vaccine failed to induce higher grow...

Full description

Bibliographic Details
Main Authors: Kazutoyo Miura, Suwani Perera, Sarah Brockley, Hong Zhou, Joan A Aebig, Samuel E Moretz, Louis H Miller, Ogobara K Doumbo, Issaka Sagara, Alassane Dicko, Ruth D Ellis, Carole A Long
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3113848?pdf=render
_version_ 1831750983360708608
author Kazutoyo Miura
Suwani Perera
Sarah Brockley
Hong Zhou
Joan A Aebig
Samuel E Moretz
Louis H Miller
Ogobara K Doumbo
Issaka Sagara
Alassane Dicko
Ruth D Ellis
Carole A Long
author_facet Kazutoyo Miura
Suwani Perera
Sarah Brockley
Hong Zhou
Joan A Aebig
Samuel E Moretz
Louis H Miller
Ogobara K Doumbo
Issaka Sagara
Alassane Dicko
Ruth D Ellis
Carole A Long
author_sort Kazutoyo Miura
collection DOAJ
description Apical membrane antigen 1 (AMA1) is one of the best-studied blood-stage malaria vaccine candidates. When an AMA1 vaccine was tested in a malaria naïve population, it induced functionally active antibodies judged by Growth Inhibition Assay (GIA). However, the same vaccine failed to induce higher growth-inhibitory activity in adults living in a malaria endemic area. Vaccination did induce functionally active antibodies in malaria-exposed children with less than 20% inhibition in GIA at baseline, but not in children with more than that level of baseline inhibition.Total IgGs were purified from plasmas collected from the pediatric trial before and after immunization and pools of total IgGs were made. Another set of total IgGs was purified from U.S. adults immunized with AMA1 (US-total IgG). From these total IgGs, AMA1-specific and non-AMA1 IgGs were affinity purified and the functional activity of these IgGs was evaluated by GIA. Competition ELISA was performed with the U.S.-total IgG and non-AMA1 IgGs from malaria-exposed children.AMA1-specific IgGs from malaria-exposed children and U.S. vaccinees showed similar growth-inhibitory activity at the same concentrations. When mixed with U.S.-total IgG, non-AMA1 IgGs from children showed an interference effect in GIA. Interestingly, the interference effect was higher with non-AMA1 IgGs from higher titer pools. The non-AMA1 IgGs did not compete with anti-AMA1 antibody in U.S.-total IgG in the competition ELISA.Children living in a malaria endemic area have a fraction of IgGs that interferes with the biological activity of anti-AMA1 antibody as judged by GIA. While the mechanism of interference is not resolved in this study, these results suggest it is not caused by direct competition between non-AMA1 IgG and AMA1 protein. This study indicates that anti-malaria IgGs induced by natural exposure may interfere with the biological effect of antibody induced by an AMA1-based vaccine in the target population.
first_indexed 2024-12-21T22:36:58Z
format Article
id doaj.art-6610d76e65cf4f5a9466e87c866db5ca
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T22:36:58Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6610d76e65cf4f5a9466e87c866db5ca2022-12-21T18:47:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0166e2094710.1371/journal.pone.0020947Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.Kazutoyo MiuraSuwani PereraSarah BrockleyHong ZhouJoan A AebigSamuel E MoretzLouis H MillerOgobara K DoumboIssaka SagaraAlassane DickoRuth D EllisCarole A LongApical membrane antigen 1 (AMA1) is one of the best-studied blood-stage malaria vaccine candidates. When an AMA1 vaccine was tested in a malaria naïve population, it induced functionally active antibodies judged by Growth Inhibition Assay (GIA). However, the same vaccine failed to induce higher growth-inhibitory activity in adults living in a malaria endemic area. Vaccination did induce functionally active antibodies in malaria-exposed children with less than 20% inhibition in GIA at baseline, but not in children with more than that level of baseline inhibition.Total IgGs were purified from plasmas collected from the pediatric trial before and after immunization and pools of total IgGs were made. Another set of total IgGs was purified from U.S. adults immunized with AMA1 (US-total IgG). From these total IgGs, AMA1-specific and non-AMA1 IgGs were affinity purified and the functional activity of these IgGs was evaluated by GIA. Competition ELISA was performed with the U.S.-total IgG and non-AMA1 IgGs from malaria-exposed children.AMA1-specific IgGs from malaria-exposed children and U.S. vaccinees showed similar growth-inhibitory activity at the same concentrations. When mixed with U.S.-total IgG, non-AMA1 IgGs from children showed an interference effect in GIA. Interestingly, the interference effect was higher with non-AMA1 IgGs from higher titer pools. The non-AMA1 IgGs did not compete with anti-AMA1 antibody in U.S.-total IgG in the competition ELISA.Children living in a malaria endemic area have a fraction of IgGs that interferes with the biological activity of anti-AMA1 antibody as judged by GIA. While the mechanism of interference is not resolved in this study, these results suggest it is not caused by direct competition between non-AMA1 IgG and AMA1 protein. This study indicates that anti-malaria IgGs induced by natural exposure may interfere with the biological effect of antibody induced by an AMA1-based vaccine in the target population.http://europepmc.org/articles/PMC3113848?pdf=render
spellingShingle Kazutoyo Miura
Suwani Perera
Sarah Brockley
Hong Zhou
Joan A Aebig
Samuel E Moretz
Louis H Miller
Ogobara K Doumbo
Issaka Sagara
Alassane Dicko
Ruth D Ellis
Carole A Long
Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
PLoS ONE
title Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
title_full Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
title_fullStr Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
title_full_unstemmed Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
title_short Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
title_sort non apical membrane antigen 1 ama1 iggs from malian children interfere with functional activity of ama1 iggs as judged by growth inhibition assay
url http://europepmc.org/articles/PMC3113848?pdf=render
work_keys_str_mv AT kazutoyomiura nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT suwaniperera nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT sarahbrockley nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT hongzhou nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT joanaaebig nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT samuelemoretz nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT louishmiller nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT ogobarakdoumbo nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT issakasagara nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT alassanedicko nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT ruthdellis nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay
AT carolealong nonapicalmembraneantigen1ama1iggsfrommalianchildreninterferewithfunctionalactivityofama1iggsasjudgedbygrowthinhibitionassay